​

Oncology Institute (TOI) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Oncology Institute Revenue Highlights

Latest Revenue (Y)

$502.73M

Latest Revenue (Q)

$136.56M

Main Segment (Y)

Health Care, Patient Service

Oncology Institute Revenue by Period

Oncology Institute Revenue by Year

DateRevenueChange
2025-12-31$502.73M27.79%
2024-12-31$393.41M21.33%
2023-12-31$324.24M28.42%
2022-12-31$252.48M24.37%
2021-12-31$203.00M8.26%
2020-12-31$187.51M20.66%
2019-12-31$155.41M37.33%
2018-12-31$113.16M-

Oncology Institute generated $502.73M in revenue during NA 2025, up 27.79% compared to the previous quarter, and up 268.10% compared to the same period a year ago.

Oncology Institute Revenue by Quarter

DateRevenueChange
2025-09-30$136.56M13.99%
2025-06-30$119.80M14.75%
2025-03-31$104.41M4.13%
2024-12-31$100.27M0.37%
2024-09-30$99.90M1.34%
2024-06-30$98.58M4.13%
2024-03-31$94.67M10.35%
2023-12-31$85.79M4.57%
2023-09-30$82.03M2.26%
2023-06-30$80.22M5.29%
2023-03-31$76.19M6.68%
2022-12-31$71.42M9.92%
2022-09-30$64.98M6.66%
2022-06-30$60.92M10.44%
2022-03-31$55.16M5.46%
2021-12-31$52.30M0.06%
2021-09-30$52.27M4.88%
2021-06-30$49.84M2.60%
2021-03-31$48.58M-74.09%
2020-12-31$187.51M296.86%
2020-09-30$47.25M-0.06%
2020-06-30$47.28M7.40%
2020-03-31$44.02M17.83%
2018-12-31$37.36M-

Oncology Institute generated $136.56M in revenue during Q3 2025, up 13.99% compared to the previous quarter, and up 138.53% compared to the same period a year ago.

Oncology Institute Revenue Breakdown

Oncology Institute Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24Dec 23Dec 22Dec 21
Clinical Research Trials And Other Revenue$4.56M$8.61M$6.90M$6.36M$6.38M
Capitated Revenue$80.48M$68.69M$70.37M$61.34M$54.28M
Health Care, Patient Service$228.99M$204.88M$213.50M$166.78M$124.07M
Fee For Service$148.51M$136.20M$143.13M$105.44M$69.79M
Dispensary Revenue-$179.92M$103.83M$79.34M$72.55M

Oncology Institute's latest annual revenue breakdown by segment (product or service), as of Dec 25: Health Care, Patient Service (49.51%), Fee For Service (32.11%), Capitated Revenue (17.40%), and Clinical Research Trials And Other Revenue (0.99%).

Quarterly Revenue by Product

Product/ServiceDec 25Jun 25Mar 25Dec 24Sep 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
Health Care, Patient Service$120.03M$55.89M$53.07M$102.68M$49.75M$52.45M$109.81M$53.43M$50.27M$47.99M$44.63M$39.11M$35.06M
Capitated Revenue$44.14M$18.84M$17.50M$36.21M$14.81M$17.67M$37.02M$16.79M$16.57M$16.53M$16.36M$13.94M$14.52M
Clinical Research Trials And Other Revenue$1.18M$1.34M$2.04M$4.14M$1.94M$2.53M$3.62M$1.60M$1.68M$1.82M$1.51M$1.59M$1.43M
Fee For Service$75.89M$37.05M$35.57M$66.47M$34.94M$34.79M$72.79M$36.64M$33.70M$31.47M$28.27M$25.16M$20.54M
Dispensary Revenue-$62.57M$49.29M$92.03M$48.21M$39.68M$54.40M$25.20M$24.24M$21.61M$18.84M$20.22M$18.68M

Oncology Institute's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Health Care, Patient Service (49.76%), Fee For Service (31.46%), Capitated Revenue (18.30%), and Clinical Research Trials And Other Revenue (0.49%).

Oncology Institute Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
AGLAgilon Health$5.93B$1.44B
EHABEnhabit$1.06B$266.10M
CCRNCross Country Healthcare$1.05B-
AUNAAuna$1.04B$286.20M
TOIOncology Institute$502.73M$136.56M
SNDASonida Senior Living$381.14M$98.04M
EOLSEvolus$294.96M$68.97M
KIDSOrthoPediatrics$236.35M$61.25M
TMCITreace Medical Concepts$212.69M$47.39M
CBLLCeriBell$89.06M$22.59M
AUTLAutolus Therapeutics$10.12M$21.14M

TOI Revenue FAQ

What is Oncology Institute’s yearly revenue?

Oncology Institute's yearly revenue for 2025 was $502.73M, representing an increase of 27.79% compared to 2024. The company's yearly revenue for 2024 was $393.41M, representing an increase of 21.33% compared to 2023. TOI's yearly revenue for 2023 was $324.24M, representing an increase of 28.42% compared to 2022.

What is Oncology Institute’s quarterly revenue?

Oncology Institute's quarterly revenue for Q3 2025 was $136.56M, a 13.99% increase from the previous quarter (Q2 2025), and a 36.70% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $119.8M, a 14.75% increase from the previous quarter (Q1 2025), and a 21.53% increase year-over-year (Q2 2024). TOI's quarterly revenue for Q1 2025 was $104.41M, a 4.13% increase from the previous quarter (Q4 2024), and a 10.29% increase year-over-year (Q1 2024).

What is Oncology Institute’s revenue growth rate?

Oncology Institute's revenue growth rate for the last 3 years (2023-2025) was 55.05%, and for the last 5 years (2021-2025) was 147.65%.

What are Oncology Institute’s revenue streams?

Oncology Institute's revenue streams in c 25 are Clinical Research Trials And Other Revenue, Capitated Revenue, Health Care, Patient Service, and Fee For Service. Clinical Research Trials And Other Revenue generated $4.56M in revenue, accounting 0.99% of the company's total revenue, down -47.03% year-over-year. Capitated Revenue generated $80.48M in revenue, accounting 17.40% of the company's total revenue, up 17.17% year-over-year. Health Care, Patient Service generated $228.99M in revenue, accounting 49.51% of the company's total revenue, up 11.77% year-over-year. Fee For Service generated $148.51M in revenue, accounting 32.11% of the company's total revenue, up 9.04% year-over-year.

What is Oncology Institute’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Oncology Institute was Health Care, Patient Service. This segment made a revenue of $228.99M, representing 49.51% of the company's total revenue.